# Freddie C. Hamdy

Source: https://onco.cc/people/freddie-hamdy/  
OnCo record `freddie-hamdy` (Person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Led ProtecT, the trial that showed monitoring, surgery and radiotherapy give equally low prostate cancer death rates at 15 years.

## Summary

Freddie Hamdy was chief investigator of ProtecT, the UK randomised trial of active monitoring, prostatectomy and radiotherapy for PSA-detected localised prostate cancer, whose 10- and 15-year results showed very low and similar mortality across arms and made active surveillance a mainstream choice. He also co-led the CAP screening trial. He leads urological research in Oxford.

## Fields

- Kind: Person
- Last checked: 2026-09-10
- Tags: prostate; surgery; active-surveillance
- Role: Nuffield Professor of Surgery, University of Oxford
- Specialisms: Prostate cancer; Active surveillance; Urological surgery; Screening

## Sources

- PubMed: https://pubmed.ncbi.nlm.nih.gov/?term=Hamdy%20FC%5BAuthor%5D%20ProtecT

## Connected records

- cancers: [Prostate cancer](https://onco.cc/cancers/prostate/)
- technologies: [Robotic & minimally invasive surgery](https://onco.cc/technologies/robotic-surgery/)
- institutions: [Oxford Cancer (Oxford University Hospitals and University of Oxford)](https://onco.cc/institutions/oxford-cancer/)
- trials: [ProtecT](https://onco.cc/trials/protect/)
- people: [Jenny Donovan](https://onco.cc/people/jenny-donovan/)

---
JSON: https://onco.cc/api/v1/entities/freddie-hamdy.json